OII Stock Analysis: Oceaneering International | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 4.199m USD | 12M Return: 99.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 41.4M
EPS Trend: 98.2%
Qual. Beats: 0
Rev. Trend: 96.0%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Oceaneering International, Inc. (OII) is a Houston-based provider of engineered services, products, and robotic solutions serving the offshore energy, defense, aerospace, and manufacturing industries. Founded in 1964 and operating internationally across the U.S., Africa, the U.K., Norway, Brazil, Asia, and Australia, the company runs through five segments: Subsea Robotics, Manufactured Products, Offshore Projects Group, Integrity Management & Digital Solutions, and Aerospace and Defense Technologies. Its core offerings include remotely operated vehicles (ROVs), umbilicals and subsea connection systems, installation and intervention services, asset integrity management, and engineering for defense and space applications.
Within the Oil & Gas Equipment & Services sector, OIIs business model centers on supplying specialized subsea robotics and hardware that support offshore drilling, production, and intervention activities. ROVs are a foundational technology in deepwater offshore operations, used for tasks ranging from wellhead installation to pipeline inspection, giving equipment-focused firms like OII a role that is tied to offshore project cycles rather than commodity prices directly.
- Subsea Robotics day rates rise with offshore drilling rebound
- Deepwater project sanctions boost Offshore Projects backlog
- Aerospace and Defense Technologies segment expands on government contract wins
| Net Income: 339.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 5.37 > 1.0 |
| NWC/Revenue: 28.11% < 20% (prev 22.99%; Δ 5.12% < -1%) |
| CFO/TA 0.13 > 3% & CFO 342.5m > Net Income 339.5m |
| Net Debt (601.4m) to EBITDA (413.3m): 1.45 < 3 |
| Current Ratio: 2.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.6m) vs 12m ago -1.27% < -2% |
| Gross Margin: 20.01% > 18% (prev 19.30%; Δ 0.71% > 0.5%) |
| Asset Turnover: 113.9% > 50% (prev 120.3%; Δ -6.34% > 0%) |
| Interest Coverage Ratio: 8.33 > 6 (EBIT TTM 308.4m / Interest Expense TTM 37.0m) |
| A: 0.30 (Total Current Assets 1.52b - Total Current Liabilities 729.2m) / Total Assets 2.64b |
| B: 0.74 (Retained Earnings 1.96b / Total Assets 2.64b) |
| C: 0.13 (EBIT TTM 308.4m / Avg Total Assets 2.46b) |
| D: 0.72 (Book Value of Equity 1.11b / Total Liabilities 1.53b) |
| Altman-Z'' = 5.98 = AAA |
| DSRI: 0.91 (Receivables 596.3m/641.0m, Revenue 2.80b/2.74b) |
| GMI: 0.96 (GM 19.30% / 20.01%) |
| AQI: -6.13 (AQ_t -0.52 / AQ_t-1 0.09) |
| SGI: 1.02 (Revenue 2.80b / 2.74b) |
| TATA: -0.00 (NI 339.5m - CFO 342.5m) / TA 2.64b) |
| Beneish M = -7.35 (Cap -4..+1) = AAA |
As of July 14, 2026, the stock is trading at USD 42.10 with a total of 617,620 shares traded. Over the past week, the price has changed by +9.35%, over one month by +6.88%, over three months by +12.48% and over the past year by +99.53%.
Current recommended Stop Loss: 38.60 (which is 8.3% or 2.2 ATR below the current price).
Oceaneering International has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold OII.
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 36.5 | -13.3% |
P/E Trailing = 12.5298
P/E Forward = 18.7617
P/S = 1.4986
P/B = 3.7944
P/EG = 8.0091
Revenue TTM = 2.80b USD
EBIT TTM = 308.4m USD
EBITDA TTM = 413.3m USD
Long Term Debt = 488.8m USD (from longTermDebt, last quarter)
Short Term Debt = 128.8m USD (from shortTermDebt, last quarter)
Debt = 1.21b USD (from shortLongTermDebtTotal, last quarter) + Leases 360.0m
Net Debt = 601.4m USD (calculated: Debt 1.21b - CCE 607.5m)
Enterprise Value = 4.80b USD (4.20b + Debt 1.21b - CCE 607.5m)
Interest Coverage Ratio = 8.33 (Ebit TTM 308.4m / Interest Expense TTM 37.0m)
EV/FCF = 19.99x (Enterprise Value 4.80b / FCF TTM 240.1m)
FCF Yield = 5.00% (FCF TTM 240.1m / Enterprise Value 4.80b)
FCF Margin = 8.57% (FCF TTM 240.1m / Revenue TTM 2.80b)
Net Margin = 12.12% (Net Income TTM 339.5m / Revenue TTM 2.80b)
Gross Margin = 20.01% ((Revenue TTM 2.80b - Cost of Revenue TTM 2.24b) / Revenue TTM)
Gross Margin QoQ = 18.38% (prev 19.78%)
Tobins Q-Ratio = 1.82 (Enterprise Value 4.80b / Total Assets 2.64b)
Interest Expense / Debt = 3.06% (Interest Expense 37.0m / Debt 1.21b)
Taxrate = 34.15% (18.7m / 54.8m)
NOPAT = 203.1m (EBIT 308.4m * (1 - 34.15%))
Current Ratio = 2.08 (Total Current Assets 1.52b / Total Current Liabilities 729.2m)
Debt / Equity = 1.09 (Debt 1.21b / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 1.45 (Net Debt 601.4m / EBITDA 413.3m)
Debt / FCF = 2.50 (Net Debt 601.4m / FCF TTM 240.1m)
Total Stockholder Equity = 981.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.81% (Net Income 339.5m / Total Assets 2.64b)
RoE = 34.58% (Net Income TTM 339.5m / Total Stockholder Equity 981.8m)
RoCE = 20.97% (EBIT 308.4m / Capital Employed (Equity 981.8m + L.T.Debt 488.8m))
RoIC = 10.67% (NOPAT 203.1m / Invested Capital 1.90b)
WACC = 9.47% (E(4.20b)/V(5.41b) * Re(11.61%) + D(1.21b)/V(5.41b) * Rd(3.06%) * (1-Tc(0.34)))
Discount Rate = 11.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.89 | Cagr: -0.76%
[DCF] Terminal Value 74.44% ; FCFF base≈177.9m ; Y1≈203.9m ; Y5≈300.1m
[DCF] Fair Price = 31.81 (EV 3.77b - Net Debt 601.4m = Equity 3.17b / Shares 99.7m; r=9.47% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.19 | EPS CAGR: 57.47% | SUE: -0.43 | # QB: 0
Revenue Correlation: 95.98 | Revenue CAGR: 8.81% | SUE: 1.21 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.45 | Chg30d=-0.36% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.52 | Chg30d=+5.39% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=1.90 | Chg30d=+0.68% | Revisions=+25% | GrowthEPS=-1.5% | GrowthRev=+4.8%
EPS next Year (2027-12-31): EPS=2.13 | Chg30d=+2.29% | Revisions=+25% | GrowthEPS=+12.1% | GrowthRev=+6.2%
[Analyst] Revisions Ratio: +22% (up=4, down=2)